Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ialurex versus Systane for dry eye syndrome
2007-005882-37Phase 4Completed
- Sponsor
- Bausch + Lomb
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in dry eye syndrome (DED) comparing Ialurex with Systane (2 arms). Primary endpoint: Improvement of fluorescein corneal staining. Started Oct 2008; status: completed.
02
Drugs
sodium hyaluronatelanolin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2007-005882-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005882-37.